Jazz Pharmaceuticals plc ( JAZZ) - Key Metrics
JAZZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $19.12 | $3.05 | $6.58 | $6.29 |
| 2026Q1 | $17.27 | $4.74 | $6.59 | $6.28 |
| 2025Q4 | $19.64 | $3.34 | $5.94 | $4.87 |
| 2025Q3 | $18.55 | $4.14 | $7.82 | $7.57 |
| 2025Q2 | $17.09 | -$11.74 | $1.45 | $1.65 |
JAZZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 19.75 |
| 2026Q1 | 0% | 9.99 |
| 2025Q4 | 0% | 12.96 |
| 2025Q3 | 0% | 7.96 |
| 2025Q2 | 0% | -2.26 |
JAZZ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.61% | 0% |
| 2026Q1 | 3.32% | 0% |
| 2025Q4 | 2.86% | 0% |
| 2025Q3 | 5.74% | 0% |
| 2025Q2 | 1.55% | 0% |
JAZZ
Price: $246.81
52 week price:
Payout Ratio Range:
Earnings Per Share: 14.62 USD
P/E Ratio: 17.55
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 468012
Ebitda: 136.8 millionMarket Capitalization: 15.5 billion